Understanding the Key Role of FcRn in Anti-AChR Antibody Positive gMG
Nicholas J. Silvestri, MD, FAAN
PeerExamining 2 Treatment Options for Anti-AChR Antibody Positive gMG: An Overview of the Trial Designs
Charulatha P. Nagar, MD
PeerTreating Anti-AChR Antibody Positive gMG: Clinical Trials for 2 Treatment Options
Tuan H. Vu, MD
PeerUnderstanding the Dosing and Administration of 2 Treatment Options for Anti-AChR Antibody Positive gMG
Jennifer Buczyner, MD
PeerUnderstanding Individualized Treatment Goals for gMG
Beth Stein, MD
PeerSupporting Adult Patients With Anti-AChR Antibody Positive gMG in Their Treatment Journeys: A Look at a Program
Andrew Gordon, MD
PeerIdentifying Appropriate Patients for Acute Seizure Treatment
Sheryl Haut, MD
PeerAdvances in Acute Seizure Treatment Options
Lawrence Hirsch, MD
PeerDiving into a Treatment for Seizure Clusters Through Patient Case Studies
David Burdette, MD
PeerEmpower Your Patients With a Seizure Action Plan
Lawrence Hirsch, MD
PeerPTSD Unmet Needs: A Lens on Burden, Impact, and Treatment Challenges
Navigating PTSD: Expert Insights on Diagnosis and Challenges
Addressing Unresolved Symptoms of Major Depressive Disorder
Partial Response in Major Depressive Disorder Treatment: Are We Doing Enough?